Safety and effectiveness of remdesivir in hospitalized patients with COVID-19 and severe renal impairment: experience at a large medical center.
Hsuan-Yu ChangChia-Chen HsuLi-Fang HuChian-Ying ChouYuh-Lih ChangChih-Chia LuLi-Jen ChangPublished in: Annals of medicine (2024)
Hospitalized COVID-19 patients receiving remdesivir with severe renal impairment had an increased risk of AKI, hospital mortality, and COVID-19 disease progression compared to patients without severe renal impairment.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- early onset
- ejection fraction
- newly diagnosed
- chronic kidney disease
- randomized controlled trial
- healthcare
- systematic review
- peritoneal dialysis
- prognostic factors
- cardiovascular events
- risk factors
- drug induced
- type diabetes
- cardiovascular disease
- patient reported outcomes
- adverse drug